Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P174 – Table 1. Resolution of NPAEs after switch to DOR‐based regimen.
EVF/FTC/TDF DRV/r + 2 NRTIs
Switched to DOR regimen at week 96 269 233
NPAE during DB phase (week 0‐96) 155 (57.6%) 41 (17.6%)
NPAE ongoing at week 96 26 (9.7%) 15 (6.4%)
NPAE still ongoing at week 192 after switch to DOR 7 (2.6%) 9 (3.9%)
New NPAE after switch to DOR (week 96‐192) 25 (9.3%) 18 (7.7%)
New NPAE still ongoing at week 192 10 (3.7%) 7 (3.0%)